Crinetics Pharmaceuticals Inc buy Morgan Stanley
Start price
29.09.25
/
50%
€37.40
Target price
29.09.26
€65.69
Performance (%)
96.90%
Price
28.07.26
€73.64
Summary
This prediction is currently active. With a performance of 96.90% the BUY prediction by Morgan_Stanley is a big success. This prediction currently runs until 29.09.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Crinetics Pharmaceuticals Inc | 0.245% | 0.245% |
| iShares Core DAX® | 1,72 % | 3,37 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % |
| iShares S&P 500 | -0,89 % | 1,69 % |
Comments by Morgan_Stanley for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals (NASDAQ:CRNX) had its price target raised by analysts at Morgan Stanley from $65.00 to $77.00. They now have an "overweight" rating on the stock.
Ratings data for CRNX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€39.40
06.01.26
06.01.26
€68.23
06.01.27
06.01.27
86.90%
28.07.26
28.07.26
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€44.80
23.05.24
23.05.24
€64.64
23.05.25
23.05.25
-42.86%
24.05.25
24.05.25